Abstract
Hepatic hemangiomas are the most common benign tumors of the liver. Transarterial bleomycin–Lipiodol embolization (B/LE) is an effective alternative treatment for symptomatic hemangiomas. The purpose of this study is to investigate the long-term feasibility, efficacy, and safety of Transarterial bleomycin–Lipiodol embolization (B/LE) in the management of symptomatic giant liver hemangioma (GLH).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
